Form 4: Mustang Bio CEO Manuel Litchman Reports Share Relinquishment for Tax Obligations
SEC Form 4 Filing
CEO Manuel Litchman relinquished 27 shares of Mustang Bio common stock to cover tax liabilities related to vesting restricted stock units.
Summary
- On April 24, 2025, Manuel Litchman, the President, CEO, and Interim CFO of Mustang Bio, Inc., reported a transaction involving the relinquishment of 27 shares of common stock to cover tax liabilities.
- The shares were relinquished at a price of $1.24 per share.
- Following the transaction, Litchman directly owns 1,634 shares of Mustang Bio common stock.
- The reported amounts reflect a one-for-fifty reverse stock split that Mustang Bio enacted on January 15, 2025.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to insider stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade in their company's stock. This filing indicates a transaction related to tax obligations from vested stock units, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 01/15/2025 | Effective date of the one-for-fifty reverse stock split. |
| 04/24/2025 | Date of the transaction where 27 shares were relinquished to cover tax liability. |
| 04/28/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Mustang Bio, MBIO, Manuel Litchman, Stock Relinquishment, Tax Liability, Reverse Stock Split, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.